These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9787892)

  • 1. The lower limits of dexamethasone window in Chinese depressives.
    Shiah IS; Ko HC; Lu RB
    Biol Psychiatry; 1998 Oct; 44(7):648-55. PubMed ID: 9787892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma dexamethasone concentrations and the dexamethasone suppression test.
    Ritchie JC; Belkin BM; Krishnan KR; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1990 Jan; 27(2):159-73. PubMed ID: 2294980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results.
    O'Sullivan BT; Hunt GE; Johnson GF; Caterson ID
    Biol Psychiatry; 1989 Mar; 25(6):739-54. PubMed ID: 2923936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high plasma dexamethasone levels on DST sensitivity: dose-response study in depressed patients and controls.
    Hunt GE; O'Sullivan BT; Johnson GF; Caterson ID
    Psychiatry Res; 1991 Feb; 36(2):209-22. PubMed ID: 2017535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and the relationships between post-dexamethasone cortisol and ACTH levels.
    Maes M; Minner B; Suy E
    J Affect Disord; 1989; 17(1):39-46. PubMed ID: 2544636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
    Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of age on cortisol and plasma dexamethasone concentrations in depressed patients and controls.
    Hunt GE; Johnson GF; Caterson ID
    J Affect Disord; 1989; 17(1):21-32. PubMed ID: 2525575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An augmented escape of androstenedione from suppression by dexamethasone in melancholia: relationships to intact ACTH and cortisol nonsuppression.
    Maes M; Van Gastel A; Blockx P; Martin M; Cosyns P; Scharpé S; Desnyder R
    J Affect Disord; 1995 Aug; 34(4):291-300. PubMed ID: 8550955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone kinetics in depressed patients before and after clinical response.
    Maguire KP; Tuckwell VM; Schweitzer I; Tiller JW; Davies BM
    Psychoneuroendocrinology; 1990; 15(2):113-23. PubMed ID: 2359809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified dexamethasone suppression test for endogenous depression.
    Poland RE; Rubin RT; Lane LA; Martin DJ; Rose DE; Lesser IM
    Psychiatry Res; 1985 Aug; 15(4):293-9. PubMed ID: 3865246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects.
    O'Sullivan BT; Cutler DJ; Hunt GE; Walters C; Johnson GF; Caterson ID
    Biol Psychiatry; 1997 Mar; 41(5):574-84. PubMed ID: 9046990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic caffeine consumption and the dexamethasone suppression test in depression.
    Lee MA; Flegel P; Cameron OG; Greden JF
    Psychiatry Res; 1988 Apr; 24(1):61-5. PubMed ID: 3393618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy.
    Devanand DP; Decina P; Sackeim HA; Hopkins N; Novacenko H; Malitz S
    Biol Psychiatry; 1987 Apr; 22(4):463-72. PubMed ID: 3567261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
    Schweitzer I; Tuckwell VM; Maguire KP; Tiller JW; Harrison LC; Davies BM
    Psychoneuroendocrinology; 1991; 16(5):375-82. PubMed ID: 1805291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN; Sharma RP; Janicak PG; Davis JM
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPA hyperactivity with increased plasma cortisol affects dexamethasone metabolism and DST outcome.
    Stokes PE; Sikes C; Lasley B; Stoll P
    J Psychiatr Res; 2002; 36(6):417-21. PubMed ID: 12393311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma dexamethasone levels in children given the dexamethasone suppression test.
    Naylor MW; Greden JF; Alessi NE
    Biol Psychiatry; 1990 Mar; 27(6):592-600. PubMed ID: 2322618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M; De Ruyter M; Suy E
    Psychoneuroendocrinology; 1989; 14(3):231-9. PubMed ID: 2756075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.